Evidence map›Paper›PMID 34514770›Full record

Trial reportJBRA assisted reproduction2022

Effects of Autologous Platelet-Rich Plasma in women with repeated implantation failure undergoing assisted reproduction.

Afsaneh Shah Bakhsh, Narges Maleki, Mohammad Reza Sadeghi, Ali SadeghiTabar, Maryam Tavakoli, Simin Zafardoust, Atousa Karimi, Sonai Askari, Sheyda Jouhari, Afsaneh Mohammadzadeh

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in JBRA assisted reproduction, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 5 pooled it
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 5 syntheses or guidelines pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Autologous platelet-rich plasma for assisted reproduction.The Cochrane database of systematic reviews · 2024
    Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Afsaneh Shah BakhshAvicenna Fertility Clinic, Avicenna Research Institute, ACECR, Tehran, Iran.
Narges MalekiAvicenna Fertility Clinic, Avicenna Research Institute, ACECR, Tehran, Iran.
Mohammad Reza SadeghiAvicenna Fertility Clinic, Avicenna Research Institute, ACECR, Tehran, Iran.
Ali SadeghiTabarMonoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran.
Maryam TavakoliReproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran.
Simin ZafardoustNanobiotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran.
Atousa KarimiAvicenna Fertility Clinic, Avicenna Research Institute, ACECR, Tehran, Iran.
Sonai AskariAvicenna Fertility Clinic, Avicenna Research Institute, ACECR, Tehran, Iran.
Sheyda JouhariAvicenna Fertility Clinic, Avicenna Research Institute, ACECR, Tehran, Iran.
Afsaneh MohammadzadehAvicenna Fertility Clinic, Avicenna Research Institute, ACECR, Tehran, Iran.
Academic Center for Education, Culture and Research · IRBiotechnology Research Center · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveRepeated implantation failure (RIF) is a major challenge in reproductive medicine. On the other hand, there has not yet been established a confirmed outcome regarding the usage of platelet-rich plasma (PRP) in women undergoing intracytoplasmic injection (ICSI) or in-vitro fertilization (IVF); hence, the objective of this study was to evaluate the effect of the intrauterine infusion of PRP on pregnancy outcomes in women undergoing ICSI.

methodsIn this prospective double-blind clinical trial, 100 women with at least two previous unexplained RIF, who were candidates for frozen-thawed embryo transfer, were allocated into two groups. One subgroup of patients was treated by intrauterine infusion of PRP (0.5CC, contained platelet 4-5 times more than a peripheral blood sample, which was performed 48 hours before blastocyst transfer) and the other subgroup was treated by intrauterine catheterization only. We compared the implantation rates between the two groups.

resultsThe pregnancy rate was 20% in the intervention subgroup, while in the control subgroup it was 13.33%; therefore, there was a significant statistical difference between the two groups.

conclusionsAccording to this paper, PRP could be successful in improving the pregnancy outcome in RIF patients, and we highly recommend other studies with larger samples to confirm the PRP therapy efficacy in RIF patients.

Indexed as

Embryo ImplantationPlatelet-Rich PlasmaEmbryo TransferFemaleFertilization in VitroHumansPregnancyPregnancy RateProspective Studiesintracytoplasmic injectionplatelet-rich plasmaPRPrecurrent implantation failure

Identifiers

PMID34514770
PMCPMC8769172
OpenAlexW3199567919

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.